Patents/Inventors

Kallanthottathil G. Rajeev

Wayland, MAUS35 patents

35 Patents

US125903052026
Complement Component C5 Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US125695702026
Compositions and Methods for Targeted RNA Delivery
VERVE THERAPEUTICS, Inc.
0 cites
US124602062025
PCSK9 Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US124537762025
Lipids and Compositions for the Delivery of Therapeutics
ARBUTUS BIOPHARMA CORPORATION
0 cites
US124101222025
Lipid Formulations for Gene Editing
VERVE THERAPEUTICS, Inc.
0 cites
US123970132025
Extrahepatic Delivery
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US123647622025
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US123503382025
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US123433982025
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US122905732025
Modified Rnai Agents
Alnylam Pharmaceuticals, Inc.
0 cites
US122747532025
Compositions and Methods for Targeted RNA Delivery
VERVE THERAPEUTICS, Inc.
0 cites
US122397092025
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US122410642025
REVERSIR™ Compounds
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US122216072025
Multi-targeted Single Entity Conjugates
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US121732882024
Oligonucleotide-ligand Conjugates and Process for Their Preparation
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US121152302024
Base Editing of ANGPTL3 and Methods of Using Same for Treatment of Disease
VERVE THERAPEUTICS, Inc.
0 cites
US120716192024
SERPINA1 Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US120594682024
Carbohydrate Conjugates as Delivery Agents for Oligonucleotides
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US120496282024
Transthyretin (TTR) Irna Compositions and Methods of Use Thereof for Treating or Preventing Ttr-associated Diseases
Alnylam Pharmaceuticals, Inc.
0 cites
US120425412024
Lipids and Compositions for the Delivery of Therapeutics
ARBUTUS BIOPHARMA CORPORATION
0 cites
US120297952024
Base Editing of PCSK9 and Methods of Using Same for Treatment of Disease
VERVE THERAPEUTICS, Inc.
0 cites
US120233832024
Lipid Compositions
ARBUTUS BIOPHARMA CORPORATION
0 cites
US120244842024
Lipid Formulations for Gene Editing
VERVE THERAPEUTICS, Inc.
0 cites
US120050742024
Extrahepatic Delivery
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US119446872024
Carbohydrate Conjugate RNA Agents and Process for Their Preparation
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US118734912024
Complement Component C5 Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US118013062023
Compositions and Methods for Targeted RNA Delivery
Verve Therapeutics, Inc.
0 cites
US117252072023
Serpina1 Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US117124762023
Lipids and Compositions for the Delivery of Therapeutics
ARBUTUS BIOPHARMA CORPORATION
0 cites
US116791582023
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US116666532023
Carbohydrate Conjugates as Delivery Agents for Oligonucleotides
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US116334792023
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US116334802023
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US116126572023
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US115902292023
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites